TY - JOUR
T1 - Ring fusion strategy for synthesis and lead optimization of sulfur-substituted anthra[1,2-c[[1,2,5]thiadiazole-6,11-dione derivatives as promising scaffold of antitumor agents
AU - Lee, Yu Ru
AU - Chen, Tsung Chih
AU - Lee, Chia Chung
AU - Chen, Chun Liang
AU - Ahmed Ali, Ahmed Atef
AU - Tikhomirov, Alexander
AU - Guh, Jih Hwa
AU - Yu, Dah Shyong
AU - Huang, Hsu Shan
N1 - Publisher Copyright:
© 2015 Elsevier Masson SAS.
PY - 2015/9/18
Y1 - 2015/9/18
N2 - A series of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-diones were synthesized and evaluated using the cell proliferations, apoptosis and NCI-60 cell panel assays. Also, the signaling pathways that account for their activities were investigated. Compounds 2, 3, 4a, 4d, 4f, 4i, 4k, 5b, 5c, 5d, 5f, 5g, 6b, 6c, 6d, 6e, 6g, 7a and 7g were selected by NCI. Among the tested compounds, 6g appeared to be the most active compound of this series that not only induced apoptosis in DU-145 cancer cells but also attenuated the ERK1/2 and p38 signaling pathways. All test compounds exhibited diverse cytostatic and cytotoxic activities that warrant further development as potential anticancer agents.
AB - A series of sulfur-substituted anthra[1,2-c][1,2,5]thiadiazole-6,11-diones were synthesized and evaluated using the cell proliferations, apoptosis and NCI-60 cell panel assays. Also, the signaling pathways that account for their activities were investigated. Compounds 2, 3, 4a, 4d, 4f, 4i, 4k, 5b, 5c, 5d, 5f, 5g, 6b, 6c, 6d, 6e, 6g, 7a and 7g were selected by NCI. Among the tested compounds, 6g appeared to be the most active compound of this series that not only induced apoptosis in DU-145 cancer cells but also attenuated the ERK1/2 and p38 signaling pathways. All test compounds exhibited diverse cytostatic and cytotoxic activities that warrant further development as potential anticancer agents.
KW - Anthra[1 2-c][1 2 5]thiadiazole-6 11-dione
KW - Apoptosis
KW - NCI 60-cell panel assay
KW - SRB assay
KW - Thiadiazoles
UR - http://www.scopus.com/inward/record.url?scp=84941197893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941197893&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2015.07.052
DO - 10.1016/j.ejmech.2015.07.052
M3 - Article
C2 - 26344783
AN - SCOPUS:84941197893
SN - 0223-5234
VL - 102
SP - 661
EP - 676
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
ER -